One. Single. Dose.

Imagine a world where that’s all it takes to cure cancer.

Our breakthrough off-the-shelf technology can get us there.




Our Mission

Our mission at Vironexis is to conduct preclinical development and early phase clinical trials of high, sustained and controllable protein therapeutics with a single shot.

Meet our team
what drives us

Creating a disease-free future

Combine gene therapy, virus therapy, and immunotherapy to create better, easier, and safer therapies for cancer and other diseases.

An off-the-shelf solution to achieve sustained expression of bispecific proteins, joining targeted cells together.
For applications requiring regulated gene therapy, turning transgene expression on or off when needed.
A novel method for down regulating oncogene expression, drugging the previously undruggable. Combines with TransSkip to deliver a one-two punch to cancer.

Stay up to date and receive the latest news.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form